Koffijberg H, Buskens E, Granath F, Adami J, Ekbom A, Rinkel GJ, Blomqvist P. Subarachnoid haemorrhage in Sweden 1987 2002: regional incidence and case fatality rates. J Neurol Neurosurg Psy- chiatry. 2008;79:294 299. Reviewer Disclosures Reviewer Employment Research Grant Other Research Support Speakers Bureau/ Honoraria Expert Witness Ownership Interest Consultant/Advisory Board Other Opeolu Adeoye University of Cincinnati None None None None None None None Sepideh Amin- Hanjani University of Illinois at Chicago None None None None None Micrus Endovascular, 1 y ago, served as DSMB Chair* None Kevin M. Cockroft Penn State Hershey Medical Center None None None None None eV3 Neurovascular None Gary Ross Duckwiler UCLA None None None None None None Boston Scientific, patent royalties J. Claude Hemphill University of California, San Francisco None None None Raphaelson law firm* None None None Stephan Mayer Columbia University None None None None None Edge Therapeutics*; Actelion Pharmaceuticals None Gene Sung University of Southern California None None None None None None None This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be significant if (1) the person receives $10 000 or more during any 12-month period, or 5% or more of the person s gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be modest if it is less than significant under the preceding definition. *Modest. Significant. 